RILUTEK
LOE ApproachingSMriluzole
NDAORALTABLETPriority Review
Approved
Dec 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15
Clinical Trials (5)
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Started Feb 2025
27 enrolled
GlioblastomaRecurrent GlioblastomaBrain Tumor
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Started Jun 2021
1 enrolled
MelanomaMetastatic Melanoma
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Started Mar 2021
772 enrolled
Obsessive Compulsive Disorder
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Started Dec 2020
456 enrolled
Obsessive-Compulsive Disorder
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
Started Mar 2019
909 enrolled
Spinocerebellar Ataxias